Veterans' chronic back pain may be eased by natural brain molecules in new trial
NCT ID NCT05935761
First seen Jun 27, 2026 · Last updated Sep 09, 2026 · Updated 2 times
Summary
This study tests two natural brain molecules as a safe, non-addictive treatment for chronic low back pain in 108 U.S. military veterans aged 18-65. The goal is to reduce pain severity and improve daily function without the risks of opioids. Participants will receive the experimental drug or a placebo, and pain levels will be tracked over time.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Phase 2
Tests whether the treatment actually works, and watches for side effects, in a larger group.
- Participants
-
About 108 people
The number the study aims to enrol. It can still change while the study runs.
- Expected to start
-
Dec 2026
An estimate. Start dates often move.
- Expected to finish
-
Dec 2029
An estimate. End dates often move.
- Lead sponsor
-
A government agency
The lead sponsor is a US federal agency other than the NIH.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 to 65 years
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Veterans with chronic low back pain * Based on medical history and medical records, have low back pain (Thoracic Vertebrae 6 or below) present on most days for the preceding 6 months or longer, and fulfill all disease diagnostic criteria (please see disease diagnostic criteria below) * Have a weekly mean of 24-hour average pain score 4 at baseline * Negative pregnancy test if female. Sexually active subjects are required to use a medically acceptable form of birth control if they are of childbearing potential and could become pregnant during the study. A medically acceptable form of birth control includes non-hormonal intrauterine devices, surgical sterilization, or double barrier methods (e.g. diaphragm with contraceptive jelly, condom with contraceptive foam, cervical caps with contraceptive jelly). Sexual abstinence with agreement to continue abstinence or to use a medically acceptable method of contraception (as listed above) should sexual activity occur is permissible * No change in medications less than 4 weeks before baseline * No anticipated need to alter psychotropic or pain medications for the 6-wk study duration (as determined by study physician's review of records and/or discussion with prescribing physician) * Ability to fully participate in the informed consent process Exclusion Criteria: * Unstable medical or neurological illness, including seizures, renal impairment or cerebral vascular accident (CVA) * Use of oral contraceptives or other hormonal supplements-this is out of caution, as it is unknown if the study medications would impact the efficacy of hormonal contraception * Significant suicidal or homicidal ideation that necessitates intervention * Daily use of long or short-acting narcotic medications (PRN use will be considered) * Current DSM-5 diagnosis of bipolar disorder, schizophrenia, or other psychotic disorder, or cognitive disorder due to a general medical condition * Female participants who are pregnant or breast-feeding * Known allergy to study medication * History of moderate or severe TBI (mild TBI is permissible) * DSM-5 criteria met for alcohol and/or other substance abuse or dependence within past three months (excludes caffeine and nicotine) * Have received epidural steroids, facet block, nerve block or other invasive procedures aimed to reduce low back pain within the past 3 months prior to Visit 1 * Have ongoing or anticipated disability compensation or litigation issues, in the best judgment of the investigator * Have a presence of any factors/conditions, medical or other, that in the judgment of the investigator may interfere with performance of study outcome measures, such as treatment-refractory history * Have serious or unstable cardiovascular, hepatic, renal, metabolic, respiratory, or hematologic illness, symptomatic peripheral vascular disease, or other medical condition or psychiatric conditions that, in the opinion of investigator and study physician, would compromise participation or be likely to lead to hospitalization during the study
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Chronic low back pain are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
1 site. The list below names each one and where it is.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
Durham VA Medical Center, Durham, NC
Durham, North Carolina, 27705-3875, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can the Body's stress wiring explain why pain spreads and lingers?
- Can naming your feelings predict back pain relief?
- Scientists map the daily rhythms of chronic pain
- Can yoga ease back pain when recovery looks unlikely?
- Can exercise retraining rewire the nervous system in chronic back pain?
- Can gentle back vibration reset the Brain's pain response?